Effects of Semaglutide on CKD in Patients With Type 2 Diabetes by Sradha S. Kotwal, Vlado Perkovic

Get full text

Barriers to Care: New Medications and CKD by Dana Kim, Vlado Perkovic, Sradha Kotwal

Get full text

WCN24-847 SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL by Jonathan Barratt, Brad Rovin, Edward Murphy, Radko Komers, Hernán Trimarchi, Vlado Perkovic

Get full text

WCN25-716 EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS IN IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE PHASE 3 APPLAUSE-IgAN STUDY by Dmitrij Kollins, Olympia Papachristofi, Thomas Hach, Marie-Anne Valentin, Tobias Merkel, Ronny Renfurm, Vlado Perkovic

Get full text

WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY by Dmitrij Kollins, Olympia Papachristofi, Thomas Hach, Severina Jacinto-Sanders, Tobias Merkel, Ronny Renfurm, Vlado Perkovic

Get full text

WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS by Jeffrey Ha, Swapnil Hiremath, Min Jun, Suetonia Palmer, David Wheeler, Daniel Coyne, Vlado Perkovic, Sunil Badve

Get full text

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review by Brendan Smyth, Carmel Hawley, Vlado Perkovic, Mark Woodward, Konlawij Trongtrakul, Anna Haber, B Talbot, Meg Jardine

Get full text

WCN24-1001 EFFECT OF CORTICOSTEROIDS ON KIDNEY AND SAFETY OUTCOMES IN IGA NEPHROPATHY ACROSS DIFFERENT LEVELS OF PROTEINURIA AND EGFR: A POST HOC ANALYSIS OF THE TESTING STUDY by Muh Geot Wong, Jicheng Lv, Brendon Neuen, Helen Monaghan, Laurent Billot, Vlado Perkovic, Hong Zhang, Dana Kim

Get full text

WCN24-1506 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY by Vlado Perkovic, Dmitrij Kollins, Ronny Renfurm, Olympia Papachristofi, Severina Jacinto-Sanders, Tobias Merkel, Thomas Hach, Dana V. Rizk

Get full text

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis. by Song Ren, Ying Wang, Ying Wang, Li Xian, Tadashi Toyama, Meg Jardine, Guisen Li, Vlado Perkovic, Daqing Hong

Get full text

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY by Hernán Trimarchi, Jonathan Barratt, Jai Radhakrishnan, Dana V. Rizk, Bess Sorensen, Jocelyn Leiske, Zeeshan Khawaja, Kirk Campbell, Vlado Perkovic

Get full text

WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE eGFR 20-<30 mL/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS by Dmitrij Kollins, Olympia Papachristofi, Thomas Hach, Severina Jacinto-Sanders, Tobias Merkel, Robert Schmouder, Kenneth Kulmatycki, Ronny Renfurm, Vlado Perkovic

Get full text

Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis. by Thaminda Liyanage, Toshiharu Ninomiya, Amanda Wang, Amanda Wang, Bruce Neal, Min Jun, Muh Geot Wong, Meg Jardine, Graham S Hillis, Vlado Perkovic

Get full text

The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. by Vlado Perkovic, Christine Verdon, Toshiharu Ninomiya, Federica Barzi, Alan Cass, Anushka Patel, Meg Jardine, Martin Gallagher, Fiona Turnbull, John Chalmers, Jonathan Craig, Rachel Huxley

Get full text

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. by Jicheng Lv, Bruce Neal, Parya Ehteshami, Toshiharu Ninomiya, Mark Woodward, Anthony Rodgers, Haiyan Wang, Stephen MacMahon, Fiona Turnbull, Graham Hillis, John Chalmers, Vlado Perkovic

Get full text

WCN25-1567 Glomerular disease registry and Biobank (GRIT)– design and baseline results by Sradha Kotwal, Andrew Jeyaruban, Bhadran Bose, Vincent Lee, Meg Jardine, AMALI MALLAWARCHCHI, Angus Ritchie, Muh-Geot Wong, Angela Makris, Sunil Badve, Amanda Siriwardana, Kenneth Yong, Vlado Perkovic

Get full text

WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK by Sradha Kotwal, Vlado Perkovic, Meg Jardine, Priya Vart, David Wheeler, Ian de Boer, Hong Zhang, Fan Fan Hou, Yuka Sugawara, Luca De Nicola, Jose Gorriz, Hiddo Heerspink

Get full text

WCN25-888 DESIGN OF THE ZEUS TRIAL: INTERLEUKIN 6 INHIBITION WITH ZILTIVEKIMAB FOR CARDIOVASCULAR PROTECTION IN CHRONIC KIDNEY DISEASE by Vlado Perkovic, Katherine Tuttle, Naveed Sattar, A. Michael Lincoff, Ann M. Navar, Nikolaus Marx, Anders Hvelplund, Florian M.M. Baeres, Mads D. Engelmann, G. Kees Hovingh, Paul M. Ridker

Get full text

WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY by Richard Lafayette, Hernan Trimarchi, Jonathan Barratt, Kevin Carroll, Vladimír Tesar, Hong Zhang, Yusuke Suzuki, Adrian Liew, Muh Geot Wong, Lokesh Shah, Jing Xia, Cecile Fajaro, Jeffrey Hafkin, Vlado Perkovic

Get full text

WCN25-1900 Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial by Katherine Tuttle, Mustafa Arici, Ecenur Guder Arslan, Srikanth Bellary, Thomas Idorn, Linong Ji, Zdravko Kamenov, Naoki Kashihara, Johannes Mann, Kenneth Mahaffey, Vlado Perkovic, Soren Rasmussen, Peter Rossing, Peter Andreas Schytz, L. Sreenivasamurthy, Richard Pratley

Get full text